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DEVELOPMENT OF AN ELASTIC SEALANT  
FOR SURGICAL APPLICATIONS 
BIJAN DEHGHANI 
ABSTRACT The	   need	   to	   close	   wounds	   and	   prevent	   air/liquid	   leakage	   is	   commonly	   faced	   in	  surgical	  operations.	  It	  is	  a	  necessary	  step	  required	  for	  proper	  post-­‐operative	  tissue	  function	  and	  healing.	   	   	  In	  the	  past,	  sutures	  and	  staples	  have	  been	  used	  to	  carry	  out	  this	  function;	  however,	  these	  different	  methods	  each	  come	  with	  limitations	  based	  on	  material	   and	   application.	   	   Recent	   studies	   have	   shown	   sealant	   glues	   to	   be	   a	   new	  method	  with	  much	   promise	   in	   connecting	   tissues.	   Several	   commercially	   available	  products	   have	   shown	   biocompatibility,	   along	   with	   ease	   of	   application	   and	   strong	  adherence;	  however,	  these	  come	  with	  their	  own	  set	  of	  limitations.	  	  	  In	   this	   project	   I	   present	   a	   novel	   tissue	   adhering	   substance	   made	   from	   human	  protein	  elastin.	  This	  protein	  sealant	  will	  allow	  us	  to	  address	  several	  issues	  in	  tissue-­‐engineered	   materials	   such	   as	   biocompatibility,	   cytotoxicity,	   adhesion	   strength,	  binding	  in	  wet	  environment	  and	  elasticity.	  Using	  recombinant	  technology,	  we	  have	  been	   able	   to	   purify	   this	   protein	   monomer	   and	   form	   glue-­‐like	   hydrogels	   using	   a	  cross-­‐linker	  and	  UV	   light	  activator.	   	  This	  sealant	  was	   tested	   in	   in	  vitro	  models	  and	  porcine	  ex	  vivo	  lung	  model.	  The	  results	  indicate	  an	  increased	  adherence	  to	  the	  tissue	  as	  well	   as	   a	   high	   elasticity	   allowing	   the	   sealant	   to	  move	  more	   naturally	  with	   the	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tissue.	   Further	   testing	   in	   large	   animal	   in	   vivo	   studies	   will	   be	   performed	   to	   show	  safety	  and	  efficacy	  before	  being	  implemented	  into	  clinical	  practice.	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INTRODUCTION 	   	  
	   Closing	   a	   wound	   during	   a	   surgical	   operation	   is	   crucial	   to	   the	   success	   of	   the	  
procedure.	  Surgeons	  around	  the	  world	  have	  recognized	  this	  need	  as	  early	  as	  1600	  BC,	  
when	   giant	   ant	   mandibles	   were	   used	   to	   seal	   external	   wounds	   (1).	   The	   great	   Indian	  
physician,	   Sushruta,	   wrote	   about	   different	   suture	   methods	   and	   the	   materials	   used	  
(Figure	  1).	  He	  mentioned	  how	  future	  physicians	  might	  practice	  these	  techniques	  using	  
clothes	   or	   leather	   (1).	   Around	   the	   time	   of	   the	   10th	   century,	   Arab	   surgeons	   had	  made	  
much	  progress	  in	  surgery	  using	  sutures	  made	  from	  lute	  string	  and	  angled	  needles.	  While	  
these	   methods	   would	   be	   considered	   archaic	   in	   the	   modern	   operating	   room,	   they	  
allowed	  medicine	  to	  progress	  and	  grow.	  	  	  
	  
	  
Advances	   in	   technology	  have	  permitted	   the	  use	  of	  biodegradable,	  antibacterial	  
sutures,	   such	   as	   VICRYL.	   These	   materials	   are	   made	   from	   PLLA(8%)-­‐co-­‐PGA(92%)	   and	  
Figure	  1:	  Examples	  of	  Sutures	  Described	  by	  Sushruta,	  (1).	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allow	   for	  manipulation	  of	   the	  material	  parameters	   to	   increase	  or	  decrease	   the	   rate	  of	  
degradation(2).	  While	  sutures	  are	  still	  widely	  used	   in	  surgery,	   they	  primarily	  serve	   the	  
purpose	  of	  holding	  tissue	  together	  for	  fast	  healing,	  withstanding	  mechanical	  loads,	  and	  
prevention	  of	  fluid	   leakage.	   	  Suturing	  techniques	  require	  a	  high	  degree	  of	  training	  and	  
suturing	   can	   be	   challenging,	   if	   not	   impossible,	   in	   certain	   minimally	   invasive	  
procedures(3).	  Furthermore,	  the	  sutures	  can	  be	  traumatic	  to	  the	  neighboring	  tissue	  and	  
result	   in	   inflammation	   or	   cytotoxicity(3).	   	   To	   address	   these	   issues,	   surgical	   adhesives	  
have	   emerged	   as	   an	   alternative	   to	   sutures	   and	   staples	   in	   sealing	   wounds;	   these	  
materials	  can	  more	  completely	  close	  the	  wound	  and	  prevent	  air	  or	   liquid	   leakage	  with	  
higher	  efficiency	  than	  the	  standard	  suture	  (4).	  
	  Tissue	  adhesives	  can	  be	  broadly	  defined	  as	  “any	  substance	  with	  characteristics	  
that	  allow	  for	  in	  situ	  polymerization	  to	  cause	  adherence	  of	  tissue	  to	  tissue	  or	  tissue	  to	  
non-­‐tissue	  surfaces,	  as	  for	  prostheses,	  to	  control	  bleeding	  (hemostats)	  and	  to	  serve	  as	  a	  
barrier	   to	   gas	   and	   liquids	   (sealants)”	   (3).	   Several	   factors	   to	   consider	  when	  developing	  
tissue	   adhesives	   are:	   mechanical	   properties,	   ease	   of	   use,	   biocompatibility,	   immune	  
response,	  cytotoxicity,	  and	  cost	  (3,	  5).	  	  These	  materials	  have	  been	  categorized	  into	  three	  
groups:	  biological,	   synthetic,	   and	  biomimetic.	  Each	  of	   these	  categories	  poses	  different	  





Biological	   tissue	   adhesives	   are	   developed	   from	   natural	   polymers;	   these	  
compounds	  are	  congealed	  through	  biochemical	   reaction.	  The	  most	  common	  biological	  
sealants	   are	   fibrin	   based	   and	   collagen	   based.	   Fibrin	   based	   tissue	   adhesives	   use	   the	  
body’s	  natural	  clotting	  method	  to	  form	  an	  adhesive	  substance	  (Figure	  2).	  The	  products	  
are	  commercially	   sold	  under	   the	  name	  EVICEL	  and	  TISSEEL.	  While	   these	  sealants	  have	  
shown	   some	   degree	   of	   popularity	   in	   the	   operating	   room,	   they	   still	   maintain	   certain	  
inefficiencies,	   which	   have	   limited	   their	   use.	   Fibrin	   glues	   lack	   important	   mechanical	  
properties	  such	  as	  tensile	  and	  adhesive	  strength.	  Also,	  these	  glues	  are	  high	  cost,	  present	  
the	   possibility	   of	   transmitting	   viruses,	   and	   can	   require	   laborious	   preparation	   before	  
administration	   (3).	  Collagen	  based	  sealants	  have	  the	  ability	   to	  absorb	  blood	  and	  other	  
factors	  necessary	  for	  coagulation.	  Studies	  have	  revealed	  that	  the	  use	  of	  these	  sealants	  
during	  surgery	  is	  more	  effective	  at	  controlling	  hemostasis	  and	  can	  reduce	  intraoperative	  
bleeding	   when	   compared	   with	   sutures	   in	   several	   systems	   (6,	   7).	   	   The	   downside	   to	  
collagen	   based	   tissue	   adhesives	   is	   their	   tendency	   to	   swell,	   resulting	   in	   tissue	  
compression.	   This	   has	   limited	   the	   use	   of	   these	   adhesives	   in	   closed	   body	   cavities	   and	  






Synthetic,	  or	  semi-­‐synthetic,	  glues	  such	  as	  urethane	  polymers	  or	  cyanoacrylate-­‐
based	  glues	  can	  vary	  drastically	  in	  mechanical	  and	  biological	  properties.	  Of	  these	  sealant	  
types,	   cyanoacrylate	   glues	   are	   the	   most	   widely	   used	   and	   have	   been	   used	   in	   many	  
settings	  that	  range	  from	  the	  Vietnam	  War	  to	  topical	  skin	  adhesion.	  The	  primary	  concern	  
with	  cyanoacrylates,	  as	  with	  many	  synthetic	  adhesives,	  is	  the	  high	  cytotoxicity.	  For	  this	  
reason,	  these	  glues	  are	  not	  approved	  for	  internal	  use	  during	  surgical	  operations	  as	  they	  
can	   lead	   to	   necrosis	   of	   the	   tissue	   (9).	   Other	   synthetic	   glues	   are	   developed	   from	  
materials	   that	  can	  be	  photo	  polymerized	  to	  create	  hydrogels.	  An	  example	  of	  synthetic	  
hydrogel	  material	   is	   the	  FDA	  approved	  FocalSeal	   (Genzyme	  Biosurgery	   Inc,	  Cambridge	  
Figure	  2:	  Blood	  Clotting	  Cascade	  used	  in	  Fibrin	  Glue,	  (3).	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MA).	   This	   hydrogel	   is	   formed	   by	   exposing	   a	   PEG	   based	   glue	   to	   a	   standardized	   light	  
source.	   The	   use	   of	   a	   light	   source	   allows	   for	  more	   control	   of	   sealant;	   however,	   it	   also	  
adds	   an	   extra	   step	   in	   the	   process,	   which	   can	   seem	   unappealing	   in	   time	   sensitive	  
situations.	  	  
Biomimetic	  Adhesives	  
A	   major	   issue	   with	   tissue	   adhesive	   sealants	   is	   administration	   in	   a	   wet	  
environment;	  scientists	  have	  turned	  toward	  biomimetic	  systems	  to	  address	  these	  issues.	  	  
Underwater	   organisms	   have	   shown	   to	   be	   an	   ideal	   model	   to	   gain	   insight	   into	   their	  
adhesion	  mechanisms.	  One	  of	  the	  first	  organisms	  studied	  for	   its	  adhesive	  properties	   is	  
the	  blue	  mussel,	  by	  Wait	  et	  al.	  (10).	  These	  mussels	  can	  adhere	  to	  almost	  any	  surface	  by	  
secreting	   adhesive	   plaques	   attached	   to	   thread	   like	   material	   that	   is	   attached	   to	   the	  
organism	  (Figure	  3).	  	  
	  
Figure	  3:	  Blue	  Mussel	  Adhesion	  Diagram.	  A.	  Schematic	  of	  adhesive	  plaques.	  B.	  Adhesives	  plaques	  sticking	  to	  Teflon	  plate,	  (10).	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The	  adhesive	  properties	  of	  these	  plaques	  are	  so	  strong	  they	  can	  even	  bind	  to	  non-­‐stick	  
surfaces	   such	   as	   Teflon	   (11).	   This	   high	   adhesive	   property	   is	   thought	   to	   be	   a	   result	   of	  
DOPA	   amino	   acids	   present	   in	   the	   secreted	   plaques.	   These	   DOPA	   constructs	   contain	  
catecholamine	  functional	  groups,	  which	  give	  the	  extract	  its	  adhesive	  properties	  (11).	  
	  
While	  mollusk	  plaques	  have	  shown	  impressive	  adhesion	   in	  wet	  environments,	  another	  
animal	  model	  has	  been	  extensively	  studied,	  the	  gecko.	  Gecko	  lizards	  poses	  the	  ability	  to	  
reversibly	  bind	  to	  rough/uneven	  surfaces,	  nano-­‐imaging	  of	  gecko	  feet	  reveal	  mushroom	  
shaped	  setae	  filaments	  with	  spatula	  shaped	  heads	  (4),	  (Figure	  4).	  	  
This	   hierarchical	   structure	   is	   the	   key	   to	   the	   gecko’s	   ability	   to	   adhere	   to	  many	  
surfaces.	  Murphy	   et	   al.	   have	   developed	   a	   synthetic	   polyurethane	   construct	   similar	   to	  
that	  of	  the	  gecko.	  By	  applying	  the	  hierarchical	  structure,	  they	  are	  able	  to	  mimic	  proper	  
Figure	  4:	  Microscopic	  View	  of	  Gecko	  Feet	  Revealing	  the	  Hierarchical	  Structure,	  (4).	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topography	  to	  achieve	  high	  adhesive	  properties.	  They	  demonstrated	  that	  a	  1cm2	  patch	  
can	  hold	  a	  1	  kg	  weight	  in	  the	  direction	  of	  the	  oriented	  filaments;	  later	  they	  developed	  a	  
two-­‐way	  patch	  capable	  of	  adhering	  to	  surfaces	  on	  more	  than	  one	  direction	  of	  force	  (12),	  
(Figure	  5).	  This	   type	  of	  biomimetic	   thinking	  has	  allowed	  for	  many	   innovative	  creations	  
and	  has	  led	  to	  an	  improvement	  in	  patient	  care.	  
	  
Figure	   5:	   Gecko-­‐inspired	   Adhesive	   Patch.	   i-­‐iii	   displaying	   the	   angled	  hierarchical	   topography.	   iv,	  demonstrating	  the	  1	  cm2	  patch	  holding	  a	  1kg	  weight.	  v,	  displaying	  a	  two-­‐way	  post,	  (12).	  
	  
Issues	  to	  Address	  
While	  many	  tissue	  adhesives	  show	  great	  promise,	  their	  use	  in	  surgery	  is	  still	  very	  
limited.	  Surgical	  sealants	  require	  more	  than	  a	  strong	  adhesive;	  the	  glue	  should	  foster	  a	  
i	  
ii	  
iii	   iv	  
v	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proliferative	  environment	  specific	   for	  the	  tissue	   it	   is	  adhered	  too.	  Also,	   it	  should	  allow	  
the	  tissue	  to	  function	  as	  if	  no	  alterations	  have	  been	  made.	  Finally,	  the	  surgeon	  applying	  
the	  sealant	  should	  have	  a	  strong	  understanding	  of	  the	  adhesives	  indication	  and	  should	  
be	  able	  to	  determine	  how	  to	  best	  use	  the	  sealant	  (3).	  	  While	  many	  sealants	  may	  embody	  
some	  of	  these	  characteristics,	  developing	  a	  sealant	  with	  all	  of	  these	  properties	  has	  been	  
a	  challenge.	  Not	  only	  do	  we	  see	  issues	  with	  ideal	  mechanical	  properties,	  it	  may	  not	  be	  
ideal	  for	  all	  tissue	  types.	  
My	  Study	  
In	  this	  study	  we	  present	  a	  novel	  sealant,	  created	  from	  the	  human	  protein	  elastin,	  
that	  addresses	  some	  of	  the	  common	  issues	  among	  commercially	  available	  sealants.	  Our	  
sealant	   is	   synthesized	   using	   recombinant	   technology	   and	   is	   photo-­‐crosslinkable	   under	  
Ultra	  Violet	   light	  exposure.	   	  Several	  parameters	  can	  be	  altered,	   thereby	  allowing	   for	  a	  
fine-­‐tuning	  of	  the	  mechanical	  and	  degradation	  properties	  of	  the	  adhesive.	  	  The	  protein	  
sealant	   demonstrates	   highly	   elastic	   properties	   and	   can	   expand	   with	   tissue	   without	  
jeopardizing	   the	   integrity	   of	   the	   sealant.	   	   I	   will	   present	   several	   in	   vitro	   experiments	  
testing	  the	  mechanical	  properties	  of	  our	  sealant;	   furthermore,	   I	  will	  discuss	  the	  use	  of	  
this	   sealant	   in	   ex	   vivo	   animal	  models.	   The	   results	   of	   these	   studies	   have	   shown	   great	  






Preparation	  of	  Methacrylated	  Tropoelastin	  
	  
The	   design	   of	   this	   study	   required	   many	   different	   steps,	   starting	   from	   the	  
synthesis	   of	   the	   adhesive	   sealant,	   leading	   to	   the	   characterization	   of	   the	   mechanical	  
properties,	  and	  eventually,	  testing	  of	  the	  sealant	  in	  different	  animal	  models.	  	  All	  in	  vitro	  
characterization	  experiments	  where	  performed	  at	  a	  minimum	  of	  three	  trials	  to	  ensure	  a	  
statistically	  significant	  result.	  	  
	  
Methacrylating	  Tropoelastin	  	  
Recombinant	   human	   tropoelastin	  was	   kindly	   provided	   by	   our	   collaborator,	   Dr.	  
Anthony	  Weiss,	  at	  the	  University	  of	  Sydney.	  The	  tropoelastin	  is	  first	  dissolved	  in	  DPBS,	  at	  
4°C	  with	  a	  magnet	  stirrer	  spinning	  at	  moderate	  speeds,	  until	   the	  entire	  sample	   is	   fully	  
dissolved.	  Next,	  methacrylate	  anhydride	  is	  added	  in	  a	  drop-­‐wise	  fashion;	  it	  is	  crucial	  that	  
the	   methacrylate	   is	   added	   in	   drops	   to	   prevent	   clumping	   and	   precipitation.	   After	   the	  
methacrylate	  anhydride	  is	  added,	  the	  sample	  should	  be	  covered	  with	  aluminum	  foil	  to	  
prevent	  light	  exposure.	  Depending	  on	  the	  desired	  methacrylation	  degree,	  methacrylate	  
anhydride	   is	  added	   in	  a	  percent	  weight	  by	  volume:	  8%	  (low),	  15%	  (medium),	  and	  20%	  
(high).	   	   The	   methacrylate	   anhydride	   is	   allowed	   to	   react	   with	   the	   tropoelastin	   for	   24	  
hours	   in	   the	  conditions	  mentioned	  above;	  4°C,	   stirring,	  no	   light	  exposure.	  To	   stop	   the	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methacrylation	  process,	  the	  sample	  is	  diluted	  four	  fold	  by	  adding	  3x	  to	  total	  volume	  of	  
DPBS	  (if	  solution	  volume	  is	  5ml,	  add	  15	  ml	  DPBS).	  	  	  
The	   next	   step	   is	   to	   remove	   the	   residual	   methacrylate	   anhydride	   from	   the	  
solution.	  This	  involves	  using	  3.5K	  molecular	  weight	  cut-­‐off	  MINI	  Dialysis	  cups	  (Thermo-­‐
Scientific,	  Rockford	  Illinois).	  The	  samples	  are	  placed	  on	  a	  shaker	  at	  4°C	  and	  covered	  with	  
aluminum	  foil	  to	  prevent	  light	  exposure.	  The	  dialysis	  water	  is	  changed	  twice	  a	  day	  for	  10	  
days,	   or	   until	   the	   solution	   appears	   clear	   (i.e.	   no	   precipitate	   present).	   The	   dialyzed	  
samples	  are	  then	  filtered	  through	  a	  70um	  Nylon	  cell	  strainer	  (Corning	  Life	  Sciences,	  One	  
Becton	  Circle,	  Durham,	  NC)	  into	  a	  50ml	  conical	  tube.	  After	  placement	  in	  an	  -­‐80°C	  freezer	  
for	   24	   hours,	   the	   tube	   is	   moved	   to	   a	   freeze	   dryer	   until	   the	   sample	   has	   completely	  
dehydrated.	  At	  this	  point	  the	  methacrylation	  process	  is	  complete	  and	  the	  final	  product,	  
Methacrylated	  Tropoelastin	   (MeTro),	   can	  be	  kept	  at	   -­‐80°C	   for	   long-­‐term	  storage	  or	  at	  
room	  temperature	  in	  a	  decanter	  for	  short-­‐term	  storage.	  	  
	  
Preparing	  the	  Methacrylated	  Tropoelastin	  and	  Photo-­‐Initiator	  
	   To	  prepare	  MeTro,	   it	  must	   first	   be	  dissolved	   and	  mixed	  with	   a	   photo-­‐initiator.	  
MeTro	   should	   be	   dissolved	   in	   deionized	   water	   while	   kept	   on	   ice.	   Depending	   on	   the	  
methacrylation	   degree,	   the	   time	   to	   dissolve	   can	   vary	   from	   one	   to	   five	   hours;	   higher	  
methacrylation	  results	  in	  a	  longer	  time	  required	  to	  dissolve.	  	  
	   Photo-­‐initiator,	   2-­‐Hydroxy-­‐4’-­‐(2-­‐hydroxyethoxy)-­‐2-­‐methylpropiophnone,	   is	   used	  
at	  0.5%	  final	  concentration	  in	  the	  sealant.	  Because	  the	  photo-­‐initiator	  is	  soluble	  in	  warm	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temperatures,	   it	   is	  prepared	  in	  a	  2%	  stock	  solution	  with	  deionized	  water	  and	  placed	  in	  
the	  furnace	  (80°C)	  to	  dissolve.	  Once	  the	  MeTro	  solution	  has	  fully	  dissolved,	  the	  photo-­‐
initiator	  can	  be	  removed	  from	  the	  furnace	  and	  allowed	  to	  cool	  for	  a	  couple	  minutes;	  it	  
should	   be	   added	   to	   the	  MeTro	   solution	   so	   that	   the	   final	   concentration	   of	   the	   photo-­‐
initiator	  is	  0.5%	  and	  the	  final	  concentration	  of	  the	  MeTro	  should	  be	  the	  original	  desired	  
amount.	  From	  this	  point	  the	  sealant	  is	  ready	  for	  application.	  	  	  
	   	  
In	  Vitro	  Characterization	  of	  Methacrylated	  Tropoelastin	  
	  
Ultra-­‐Violet	  Light	  Exposure	  
To	  keep	  all	  other	  parameters	  consistent,	  UV	  exposure	  was	  kept	  constant	  for	  all	  
experiments.	  The	  wavelength	  was	  set	  to	  850	  nm,	  and	  exposure	  was	  at	  30	  seconds	  from	  
a	  distance	  of	  7	  cm	  from	  the	  MeTro.	  This	   is	   the	  assumed	  setup	  for	  all	  curing	  processes	  




Tensile	  tests	  were	  performed	  to	  determine	  the	  elastic	  modulus	  of	  the	  MeTro	  at	  
varying	  methacrylation	  degrees	  and	  MeTro	   concentration.	  A	   standard	  mold	   is	   created	  
using	  PDMS	  substrate,	   the	  dimensions	  of	   the	  mold	  are	  15mm	  x	  5.5mm	  x	  1.0mm;	   this	  
allows	  for	  approximately	  90ul	  of	  MeTro.	  The	  experiment	  is	  performed	  using	  an	  Instron	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5943	  equipped	  with	  a	  100	  Newton	  cell.	  The	  parameters	  for	  testing	  are	  set	  to	  expand	  at	  
10	  mm	  per	  minute	  until	  the	  sample	  fails	  (ruptures)	  or	  the	  expansion	  reaches	  100	  mm.	  
To	  hold	  the	  sample	  in	  the	  Instron	  machine,	  a	  double-­‐sided	  adhesive	  “clamp”	  is	  created	  
with	  a	  6.5mm	  gap	  in	  between	  the	  top	  and	  bottom.	  These	  experiments	  are	  performed	  at	  
different	  MeTro	  concentrations	  as	  well	  as	  varying	  methacrylation	  degrees.	  	  
	  
Burst	  Pressure	  
In	  vitro	  burst	  pressure	   is	  performed	  to	  measure	  the	  ability	  of	  MeTro	  to	  seal	  an	  
opening.	   The	   device	   is	   a	   custom-­‐built,	   machine-­‐manufactured	   pressure	   chamber	  
connected	   to	   a	   syringe	   pump,	   which	   creates	   the	   pressure,	   Figure	   2ii.	   To	   act	   as	   a	  
substrate	   for	   the	  sealant	   to	  adhere	   to,	   collagen	  sheets	  are	  used.	  These	  sheets	  are	  cut	  
into	  squares	  measuring	  4cm	  x	  4cm	  and	  soaked	  in	  PDMS	  to	  resemble	  a	  wet	  tissue.	  The	  
tissue	   is	   punctured	   using	   a	   3mm	   biopsy	   punch	   in	   the	   center	   of	   the	   square.	   To	  
standardize	  the	  amount	  of	  sealant	  administered,	  a	  1	  cm	  diameter	  vacuum	  grease	  mold	  
is	   placed	   around	   the	   punctured	   hole.	   100	   µl	   of	   sealant	   is	   added	   and	   cured	   using	   the	  
standard	  protocol,	  Figure	  2i.	  	  
Once	  the	  sample	  is	  prepared	  for	  testing,	  it	  is	  placed	  in	  between	  the	  two	  layers	  of	  
the	  chamber	  and	  stretched	  out	  till	  it	  was	  flush	  with	  the	  surface.	  The	  top	  of	  the	  channel	  
is	  then	  placed	  on	  top	  and	  tightened	  manually,	  Figure	  2i.	   It	   is	  crucial	  to	  tighten	  the	  top	  
half	   of	   the	   device	   enough	   so	   air	   cannot	   escape.	  Once	   the	   setup	   is	   ready,	   the	   syringe	  
pump	  is	  set	  to	  perfuse	  at	  rate	  of	  3ml/minute.	  Measuring	  of	  the	  burst	  pressure	  is	  done	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using	  a	  Pasco,	  PasPort	  pressure	  sensor	   (Roseville,	  CA).	   In	  vitro	  burst	  pressure	   is	   tested	  
on	  MeTro	   sealant	  with	   varying	   parameters,	   as	  well	   as	   CoSEAL,	   a	   PEG	  based	   synthetic	  
sealant	   (Baxter	  Pharmaceuticals	  Deerfield,	   Illinois),	   and	  Evicel,	   a	   fibrin	   sealant	   (OMIRX	  
biopharmaceuticals	  S.A,	  Rhode-­‐St-­‐Genèse,	  Belgium).	  
	  
Wound	  Closure	  	  	  	  
Wound	  closure	  experiments	  were	  performed	  to	  determine	   the	  adhesive	  ability	  
of	  the	  MeTro	  sealant	  when	  used	  on	  animal	  tissue	  as	  well	  as	  the	  cohesive	  properties	  of	  
the	  sealant	   to	   resist	  breaking.	  Using	   two	  glass	   slides	  edged	  with	  1cm2	  markers	  on	   the	  
ends,	   the	  tissue	  sample	   is	  adhered	  to	  each	  of	   the	  edged	  squares	  separated	  by	  a	  6	  cm	  
gap	  in	  between	  the	  glass	  slides.	  The	  tissue	  is	  cut	  in	  the	  middle,	  using	  a	  straight	  edge	  3cm	  
from	  each	  glass	   slide.	  After	   the	   tissue	   is	   cut	   completely,	  100µl	  of	   the	   tissue	   sealant	   is	  
administered	   and	   congealed	   over	   the	   cut	   tissue.	   The	   tissue	   is	   taken	   from	   a	   porcine	  
model	  and	  cut	  to	  fit	  the	  parameters	  explained	  above,	  Figure	  3i-­‐ii.	  The	  tissue	  is	  adhered	  
to	   the	   glass	   using	   cyanoacrylate	   glue	   because	   the	   adhesive	   properties	   are	   far	   higher	  
than	  we	  would	  observe	  with	  our	  sealant	  thus	  limiting	  the	  chance	  it	  will	  affect	  our	  data.	  	  
All	  experiments	  are	  performed	  on	  an	  Instron	  5943;	  the	  experimental	  parameters	  are	  set	  
to	   be	   identical	   to	   that	   of	   the	   tensile	   test.	  Wound	   closure	   experiments	   are	   performed	  





The	  lap	  shear	  test	   is	  performed	  using	  a	  single	   lap	  set	  up.	  To	  make	  these	  values	  
physiologically	  relevant,	  we	  minimized	  the	  total	  area	  of	  coverage	  while	  maintaining	  the	  
appropriate	  ratio	  consistent	  with	  ASTM	  F2255-­‐05	  standards	  for	  testing	  tissue	  adhesives	  
(13).	  A	  gelatin	  coat	  is	  applied	  to	  the	  glass	  slides	  to	  act	  as	  a	  substrate	  for	  the	  MeTro.	  This	  
is	  done	  by	  creating	  a	  20%	  Gelatin	  solution;	  next	   the	  glass	   slide	   is	  dipped	   into	  solution	  
until	  the	  designated	  region	  is	  covered.	  The	  gelatin	  must	  be	  allowed	  at	  least	  three	  hours	  
to	  fully	  dry	  before	  any	  adhesive	  can	  be	  applied,	  Figure	  4i-­‐ii.	  
	  All	   experiments	   are	   performed	   on	   an	   Instron	   5943	   with	   the	   experimental	  
parameters	   identical	   to	   those	   of	   the	   tensile	   test.	   	   Lap	   Shear	   is	   performed	   on	  MeTro	  
sealant	  with	  varying	  parameters	  as	  well	  as	  CoSEAL	  and	  Evicel	  sealants.	  	  
	  
Degradation	  Assay	  and	  Biocompatibility	  of	  MeTro	  
Subcutaneous	  degradation	  experiments	  were	  performed	   in	  a	  rat	  model.	   	  These	  
experiments	   followed	   an	   approved	   animal	   experimentation	   protocol	   with	  
implementation	   of	   appropriate	   anesthesia	   and	   euthanasia	   techniques.	   Circular	   pellets	  
are	   created	   using	   100ul	   of	   sealant	   at	   different	   MeTro	   concentrations	   and	  
methacrylation	  degrees.	  The	  pellets	  are	  inserted	  subcutaneously	  on	  the	  back	  of	  the	  	  rats	  
and	   removed	   at	   varying	   time	   intervals;	   7,	   28,	   and	   84	   days.	   The	   decrease	   in	   overall	  
weight	  and	  volume	  of	  each	  pellet	  is	  recorded	  over	  this	  period	  of	  time.	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After	   samples	  are	   removed	   from	  the	  animal,	  Hematoxylin	  and	  Eosin	   staining	   is	  
performed	  to	  evaluate	  the	  histology	  and	  check	  for	  any	  possible	  adverse	  response	  of	  the	  
tissue.	  This	  was	  done	  using	   standard	  H&E	   staining	  protocol:	  1.	  Rinse	  with	  DI	  water	   to	  
remove	  debris;	  2.	  Stain	  with	  Hematoxylin	  for	  5	  minutes;	  3.	  Rinse	  with	  DI	  water	  again;	  4.	  
Dip	   the	   samples	   twice	   in	  0.3%	  acid	  alcohol;	   5.	  Rinse	  with	  DI	  water;	   6.	   Stain	   cells	  with	  
eosin	   for	   2	   minutes;	   7.	   Finally,	   dehydrate	   samples	   and	   apply	   mounting	   media	   to	  
preserve	  the	  staining.	  	  
To	  test	  for	  the	  immune	  response,	  we	  performed	  an	  immunohistochemistry	  assay	  
specifically	  targeting	  CD68	  and	  CD3.	  Using	  rabbit	  Anti-­‐CD68	  antibodies	  (Sigma-­‐	  Aldrich	  St	  
Louis,	  MO)	  and	  rabbit	  Anti-­‐CD3	  antibodies	  (Sigma-­‐Aldrich	  St	  Louis,	  MO)	  we	  were	  able	  to	  
properly	   stain	   for	  monocyte	   specific	   immune	   response,	  CD68,	  and	   for	  T-­‐cell	   response,	  
CD3.	   We	   used	   the	   standard	   immunohistochemistry	   protocol	   recommended	   by	   the	  
manufacturer.	  	  
	  
Ex	  Vivo	  Burst	  Pressure	  –	  Porcine	  Lung	  Model	  
The	  following	  sealants	  were	  evaluated;	  1)	  Evicel	  (OMIRX	  biopharmaceuticals	  S.A,	  
Rhode-­‐St-­‐Genèse,	   Belgium)	   a	   fibrin-­‐based	   sealant,	   2)	   Bioglue	   (V-­‐Tech,	   Roskilde,	  
Denmark),	   a	   two-­‐part	   hydrogel	   glue	   consisting	   of	   purified	   bovine	   serum	   albumin	   and	  
glutaraldehyde,	   3)	   Progel	   (Neomend,	   Irvine,	   California),	   two	   part	   hydrogel	   glue	  
consisting	   of	   human	   serum	   albumin	   and	   Polyethylene	   Glycol.	   4)	   Methacrylated	  
Tropoelastin	  sealant,	  made	  from	  recombinant	  human	  tropoelastin.	  MeTro	  is	  made	  using	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our	  designated	  protocol	  to	  ensure	  optimum	  strength	  and	  elasticity	  of	  the	  material;	  the	  
sealant	   is	   congealed	  using	  a	  photo-­‐initiators	  and	  a	  UV	   light	   source.	  All	   tested	  sealants	  	  
were	   within	   their	   respective	   expiration	   date,	   any	   sealant	   passed	   that	   date	   was	  
discarded.	  	  
Ex	  Vivo	  Setup	  
An	  open	  top	  56-­‐liter	  tub	  was	  used.	  The	  tub	  was	  filled	  with	  pH	  7.2	  DPBS	  at	  37°C.	  
The	  temperature	  was	  maintained	  using	  a	  large	  heating	  plate	  and	  was	  monitored	  with	  a	  
thermometer.	  	  
Lungs	  	  
Approximately	  25	   lungs	  where	  used	   for	   the	   total	  of	   the	  experiment.	  All	   tissues	  
are	  taken	  from	  adult	  Yorkshire	  Mix	  Pigs,	  weighing	  an	  average	  of	  115	  kg.	  All	  lung	  samples	  
were	   analyzed	   for	   obvious	   defects	   or	   infections.	   Lobes	   with	   major	   defects	   were	  
excluded	  from	  the	  trials.	  Defects	  can	  include,	  but	  are	  not	  limited	  to:	  major	  lacerations,	  
blepping,	  or	   infection.	   	  The	   lungs	  were	  kept	   in	  a	  cold	  room	  at	  4°C	  prior	  to	  being	  used.	  
Time	  from	  receiving	  the	  lungs	  to	  usage	  never	  exceeded	  12	  hours.	  Before	  ventilation,	  the	  
esophagus,	   pericardium,	   and	   partial	   diaphragm	  were	   removed	   from	   the	   sample	   and,	  
depending	  on	  the	  sample	  type,	  the	  larynx	  was	  also	  removed	  if	  present.	  	  
Lungs	  were	  manually	   connected	   to	  a	  Portable	  Volume	  Ventilator	   (LP3	  Portable	  
Ventilator;	   Life	   Products	   Inc.	   Boulder	   Colorado)	   and	   ventilated	   at	   a	   constant	   positive	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pressure	   of	   10	   cmH2O	   for	   10	  minutes	   prior	   to	   experimentation,	   Figure	   6i-­‐ii.	   This	  was	  
done	  to	  ensure	  full	   recruitment	  of	   lungs	  and	  to	   further	  check	  for	  damage.	   	  Lobes	  that	  
presented	  major	  air	  leaks	  were	  excluded	  from	  the	  experiment,	  as	  were	  lobes	  that	  failed	  
to	  inflate	  appropriately.	  
Defect	  
Defects	   were	   creating	   using	   a	   procedure	   that	   produces	   consistent,	   superficial	  
wounds.	  Using	  a	  cylindrical	  mold	  measuring	  1-­‐cm	  in	  diameter,	  we	  were	  able	  to	  adhere	  
the	   mold	   to	   the	   pleura	   of	   the	   lungs	   using	   Ethyl	   2-­‐Cyanoacrylate	   Krazy	   Glue	   (Elmer’s	  
Products,	   Westerville,	   Ohio).	   Next	   a	   scalpel	   was	   used	   to	   remove	   the	   visceral	   pleural	  
layer	  attached	  to	  the	  glue,	  thereby	  creating	  a	  superficial	  1	  cm	  defect,	  Figure	  6iii-­‐iv.	  Each	  
defect	   was	   checked	   to	   ensure	   air-­‐leakage	   is	   achieved;	   lungs	   were	   ventilated	   at	   a	  




Using	  a	  volume	  control	  ventilator,	  each	  lobe	  was	  cannulated	  separately	  to	  allow	  
isolated	   control	   of	   the	   lobe.	   Each	   lobe	   was	   then	   ventilated	   at	   10	   cmH2O	   till	   fully	  
recruited.	  The	  selected	  lobe	  was	  then	  ventilated	  for	  2-­‐minute	  intervals	  and	  submerged	  
in	  the	  DPBS	  manually	  to	  check	  for	  air	  leaks.	  Respiration	  rate	  was	  set	  to	  12	  per	  minute,	  
positive	   end	   expiratory	   pressure	   =	   0.	   After	   a	   two	   minute	   interval	   the	   pressure	   was	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increased	  by	  5	  cmH2O	  increments.	  This	  process	  was	  continued	  till	  burst	  was	  achieved	  or	  
until	  a	  max	  peak	  pressure	  of	  50	  cmH2O	  was	  reached.	  The	  burst	  was	  graded	  based	  on	  the	  
Macchiarini	   scoring	   scale;	   Grade	   0	   (no	   leak),	   Grade	   1	   (countable	   bubbles),	   Grade	   2	  
(stream	   of	   bubbles),	   Grade	   3	   (coalescent	   bubbles)	   (14).	   Grading	   was	   done	   by	   visual	  
observations;	  burst	  pressure	  was	  recorded	  at	  initial	  site	  of	  bubbles.	  
Control	  Design	  and	  Sealant	  Application	  
The	  sealants	  were	  applied	  when	  ventilation	  was	  stopped	  and	  the	  lung	  was	  fully	  
deflated.	  This	  ensured	  proper	  adherence	  of	  the	  sealant	  to	  the	  tissue.	  For	  each	  sealant,	  
the	  manufacturer	  instructions	  were	  followed.	  To	  serve	  as	  a	  control	  for	  the	  experiment,	  
standard	  suturing	  protocols	  were	  applied.	  
Control	   –	  A	  box	   stitch	  was	  performed	  around	   the	  defect	  by	   a	  qualified	   cardio-­‐
thoracic	  surgeon.	  	  
Evicel	   Fibrin	   Sealant	   -­‐	   Both	   components	   of	   Evicel	   (BAC2	   and	   thrombin)	   were	  
placed	   in	   a	   37°C	   water	   bath	   until	   the	   solution	   was	   liquid	   and	   completely	  
transparent.	  The	  sealant	  was	  applied	  over	  the	  defect	  using	  a	  drip	  technique.	  The	  
sealant	  was	  allowed	  to	  settle	  for	  10	  minutes	  before	  testing.	  	  
Bioglue	  Surgical	  Adhesive	   -­‐	  This	  sealant	  was	  applied	  using	  the	   included	  double-­‐
helix	   syringe	   directly	   over	   the	   lesion.	   The	   glue	   was	   allowed	   to	   harden	   for	   2	  
minutes	  before	  testing.	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Progel	   Pleural	   Sealant	   –	   Progel’s	   components	   were	   kept	   in	   the	   4°C	   prior	   to	  
usage.	  The	  human	  serum	  albumin	  was	  mixed	  with	  precisely	  2	  mL	  of	  sterile	  water	  
and	   then	   applied	   within	   20	   minutes	   of	   making	   the	   solution.	   The	   sealant	   was	  
allowed	  to	  congeal	  for	  two	  minutes	  prior	  to	  ventilation.	  
Methacrylated	   Tropoelastin	  –	   This	   solution	  was	   prepared	   the	  morning	   of	   each	  
procedure	   to	   prevent	   any	   degradation	   of	   the	   protein.	   The	   sealant	   was	  
administered	  on	  top	  of	  the	  defect	  and	  immediately	  exposed	  to	  UV-­‐light	  850	  nm	  




In	  Vitro	  Characterization	  of	  Methacrylated	  Tropoelastin	  
	  To	  test	  the	  mechanical	  and	  biocompatible	  properties	  of	  methacrylated	  tropoelastin,	  MeTro,	   we	   primarily	   focused	   on	   two	   parameters,	   protein	   concentration	   and	  methacrylation	  degree.	  	  We	  believe	  that	  these	  two	  components	  of	  our	  hydrogel	  are	  most	   influential	   in	   determining	   its	   mechanical	   and	   adhesive	   properties.	   In	  performing	   these	   experiments	  we	  were	   able	   to	   alter	   the	   stiffness	   and	  elasticity	   of	  our	   hydrogel,	   thereby	   optimizing	   the	   parameters	   based	   on	   our	   needs	   and	   the	  requirements	  of	  hydrogel	  for	  different	  applications.	  	  
	  Tensile	  Test	  	   To	   determine	   the	   elastic	  modulus	   of	  MeTro,	  we	   performed	   a	   tensile	  test.	   	  We	   found	   that	  with	   varying	  protein	   concentration	   at	   a	   consistent	   acrylation	  degree,	  the	  elastic	  modulus	  at	  the	  same	  strain	  would	  increase	  linearly,	  Figure	  1i	  and	  iii.	   This	   outcome	   was	   also	   observed	   when	   varying	   methacrylation	   degree	   while	  holding	   the	   protein	   concentration	   constant,	   Figure	   ii	   and	   iv.	   At	   a	   consistent	  methacrylation	   degree,	   we	   found	   elastic	   modulus	   to	   increase	   sequentially	   with	  protein	   concentration;	   5%	   MeTro	   –	   16.5	   kPa,	   10%	   MeTro	   –	   27.8kPa,	   and	   20%	  MeTro	   –	   49.8kPa.	   These	   results	   were	   shown	   to	   have	   a	   statistically	   significant	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difference	  with	  a	  p	  <	  0.001,	  or	  less.	  When	  comparing	  the	  methacrylation	  degree	  we	  found	  a	  similar	  trend;	  low	  –	  19.1	  kPa;	  medium	  –	  27.8	  kPa,;	  high	  –	  44.2	  kPa.	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Burst	  Pressure	  
In	  vitro	  burst	  pressure	  experiments	  were	  performed	  with	  varying	   the	  same	  parameters	   in	   the	   tensile	   test.	   We	   performed	   this	   experiment	   using	   two	  commercially	   available	   sealants,	   Evicel	   and	   CoSEAL	   in	   order	   to	   give	   insight	   into	  approved	   surgical	   sealants	   that	   can	   be	   considered	   as	   a	   control	   or	   threshold	   to	  surpass.	  While	   these	   sealants	   function	   using	   different	  methods	   of	   action,	   the	   final	  result	  and	  use	  of	  these	  sealants	  make	  their	  mechanical	  characterization	  relevant	  to	  this	  study.	  	  When	  methacrylation	  degree	  was	  maintained	  at	  15%,	  the	  burst	  pressure	  at	  varying	  protein	   concentration	  was:	  5%	  MeTro	   -­‐	  0.12	  kPa;	  10%	  MeTro	   -­‐	  4.89	  kPa;	  20%	   MeTro	   -­‐	   11.48	   kPa,	   Figure2i-­‐ii.	   To	   test	   an	   upper	   limit,	   high	   methacrylation	  degree	   with	   20%	   MeTro	   was	   conducted;	   the	   increase	   in	   methacrylation	   degree	  resulted	   in	   a	   2.0	   kPa	   increase	   in	   burst	   pressure	   to	   13.36	   kPa.	   All	   of	   these	   results	  were	   found	   to	  be	   statistically	   significant	  with	  a	  p	  >	  0.0001.	  When	  holding	  protein	  concentration	  constant,	  the	  increase	  in	  methacrylation	  degree	  had	  a	  minor	  influence	  on	  burst	  pressure:	  low	  -­‐	  4.63	  kPa,	  medium	  -­‐	  4.89	  kPa;	  high	  -­‐	  5.08	  kPa,	  Figure	  2iii-­‐iv.	  We	   found	   our	   hydrogel	   to	   have	   a	   statistically	   significant	   greater	   burst	  pressure	   than	  both	  Evicel	   and	  CoSEAL.	  This	  was	  most	  noticeable	  when	   increasing	  the	   protein	   concentration	   of	   the	   hydrogels.	   Furthermore,	   the	   concentration	   of	  protein	   has	   a	   significantly	   greater	   influence	   on	   the	   burst	   pressure	   as	   does	   the	  methacrylation	  degree;	  however,	  based	  on	  measurements	  taken	  regarding	  elasticity	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of	   MeTro	   sealant,	   an	   equal	   influence	   of	   both	   methacrylation	   degree	   and	   protein	  concentration.	  	  
 
 
	  	  	  	  
Figure	  7:	  In	  Vitro	  Burst	  Pressure	  of	  MeTro.	  (i)	  Schematic	  of	  the	  modified	  standard	  test	  method	  for	  burst	  pressure	   test	  (ASTM	  F2392-­‐04).	  (ii)	   image	  of	  actual	   experimental	  setup	  of	   the	  pressurization	  system	  and	  pressure	   chamber.	  Representative	  graph	  of	  burst	  pressure	  with	   (iii)	   constant	  methacrylation	  degree	  and	  variable	  MeTro	  concentration	  and	  (v)	   constant	  MeTro	  concentration	  and	  variable	  methacrylation	  degree.	  Average	  burst	  pressure	  with	   (iv)	   constant	  methacrylation	  degree	  and	  variable	  MeTro	   concentration,	   and	  (vi)	   constant	   MeTro	   concentration	   and	   variable	   methacrylation	   degree	   (vi).	   Commercially	   available	  sealants:	  Evicel	   and	  CoSEAL	  were	  tested	  as	   control	   to	  compare	  with	  MeTro	  (*p	  <	  0.05,	  **p	  <	  0.01,	  ***p	  <	  0.001,	  ****p	  <	  0.0001).	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Wound	  Closure	   
 	   Wound	   closure	   tests	   were	   performed	   to	   determine	   the	   adhesive	  strength	  of	   our	  hydrogel	   sealant	  when	   attached	   to	   a	   biological	   substrate.	   Like	   the	  other	  experiments	  presented,	  we	  measured	  the	  differences	  observed	  when	  varying	  the	   protein	   concentration	   or	   the	  methacrylation	   degree.	   These	   experiments	  were	  performed	   using	   pig	   skin,	   attached	   to	   glass	   slides,	   as	   the	   biological	   substrate,	   ,	  Figure	  3i-­‐ii.	  	  	   At	   varying	   protein	   concentration	   and	   with	   medium	   methacrylation	  degree,	  the	  adhesive	  strength	  is:	  5%	  MeTro	  -­‐	  18.6	  kPa;	  10%	  MeTro	  -­‐	  31.5	  kPa;	  20%	  MeTro	  -­‐	  53.8	  kPa,	  Figure	  3iii-­‐iv.	  To	  measure	  the	  maximum	  threshold	  we	  performed	  experiments	   using	   MeTro	   with	   high	   methacrylation	   degrees	   and	   20%	   MeTro	  concentration,	   this	   yielded	   the	   highest	   adhesive	   strength	   of	   75.9	   kPa.	   Also,	   these	  experiments	  were	  performed	  on	  the	  commercially	  available	  sealants,	  Evicel,	  Coseal,	  and	  Progel;	  of	  the	  three	  commercially	  available	  sealants,	  the	  only	  one	  with	  a	  similar	  adhesive	  property	  to	  our	  sealant	  was	  Progel	  sealant.	  	  	   When	  measuring	   the	   influence	   of	  methacrylation	   degree	   at	   a	   constant	  MeTro	  concentration	  of	  10%,	  we	  found	  the	  adhesive	  strength	  to	  be:	  low	  -­‐	  18.2	  kPa,	  medium	   -­‐	   31.5	   kPa,	   and	   high	   -­‐	   51.6	   kPa,	   Figure	   3v-­‐vi.	   These	   results	   are	   almost	  identical	   to	   the	   experiments	   performed	   using	   different	   protein	   concentration.	  Having	   similar	   results	   for	   adhesive	  modulus	   can	   imply	   that	   these	   two	  parameters	  have	  an	  equal	  influence	  on	  the	  overall	  adhesive	  properties	  of	  our	  sealant.	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Figure	   8:	  Wound	   Closure	   using	   Porcine	   Skin	   as	   Biological	   Substrate	   for	   Tissue	   Adhesion.	   i)	  Schematic	  of	   the	  modified	  standard	   test	  method	   for	  adhesion	  strength	  (ASTM	  F2458-­‐05)	  of	  MeTro	  Schematic	   depicting	  wound	   closure	   experiment.	   (ii)	   Image	   of	   actual	   experimental	   setup	   of	  wound	  closure	   using	   porcine	   skin.	   Representative	   graph	   of	  wound	   closure	   experiment	  with	   (iii)	   constant	  methacrylation	  degree	  and	  variable	  MeTro	  concentration,	  and	  (v)	  constant	  MeTro	  concentration	  and	  variable	  methacrylation	  degree.	  Average	  adhesive	  strength	  with	  (iv)	  constant	  methacrylation	  degree	  and	   variable	   MeTro	   concentration,	   and	   (vi)	   constant	   MeTro	   concentration	   and	   variable	  methacrylation	  degree.	  (*p	  <	  0.05,	  **p	  <	  0.01,	  ***p	  <	  0.001,	  ****p	  <	  0.0001).	  
 Lap	  Shear	  	   Lap	  Shear	  can	  reveal	  the	  adhesive	  and	  cohesive	  properties	  of	  a	  material,	  Figure4i-­‐ii.	   While	   we	   did	   not	   directly	   record	   the	   type	   of	   break	   observed	   in	   each	  experiment,	  the	  overall	  shear	  strength	  was	  very	  consistent	  for	  all	  test	  samples.	  We	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Figure	   9:	   Lap	   Shear	   of	   MeTro	   with	   Gelatin	   Coating	   as	   Substrate	   for	   Adhesion.	   Schematic	  depicting	   wound	   closure	   technique	   (i);	   Pictures	   taken	   from	   actual	   lap	   shear	   experiment	   (ii).	  Representative	   graph	   of	   lap	   shear	   experiment	   with	   constant	   methacrylation	   degree	   and	   variable	  MeTro	  concentration	  (iii);	  Representative	  graph	  of	  lap	  shear	  with	  constant	  MeTro	  concentration	  and	  variable	  methacrylation	  degree	  (v).	  Average	  adhesive	  strength	  with	  constant	  methacrylation	  degree	  and	   variable	   MeTro	   concentration	   (iv);	   Average	   adhesive	   strength	   with	   constant	   MeTro	  concentration	   and	   variable	   methacrylation	   degree	   (vi).	   Commercially	   available	   sealants,	   Evicel,	  CoSEAL	  and	  Progel,	  were	  tested	  as	  well	  to	  compare	  with	  our	  sealant.	  	  
 Degradation	  Assay	  and	  Biocompatibility	  in	  Subcutaneous	  Rat	  Model	  	   To	   determine	   the	   biocompatibility	   and	   degradation	   of	   MeTro	   in	   vivo,	  subcutaneous	   experiments	  were	   performed	   using	   a	   rat	  model.	   In	   the	   degradation	  assay,	   we	   measured	   percent	   loss	   based	   on	   volume	   and	   weight	   of	   the	   implanted	  
	  28 
pellet.	  Similar	  to	  the	  previously	  performed	  experiments,	  both	  methacrylation	  degree	  and	  MeTro	   concentration	  were	   tested	   separately	   to	   determine	   the	   effects	   of	   each	  parameter	   on	   degradation.	   When	   holding	   methacrylation	   degree	   constant	   at	  medium	  methacrylation,	   the	   difference	   in	   volume	   loss	   and	   weight	   loss	   was	  most	  noticeable	   after	   28	   days.	   In	   both	   measurements	   it	   was	   found	   that	   higher	   MeTro	  concentration	   degraded	   at	   a	   slower	   rather	   than	   the	   lower	   MeTro	   concentration	  hydrogels.	  After	  84	  days,	  the	  5%	  MeTro	  sample	  was	  completely	  degraded,	  the	  10%	  MeTro	  sample	  degraded	  90.5%	  by	  volume	  and	  67%	  by	  weight,	  and	  the	  20%	  MeTro	  sample	  was	  65%	  degraded	  by	  volume	  and	  50%	  degraded	  by	  weight,	  Figure	  5a	  i-­‐iii.	  	  When	  protein	  concentration	  was	  constant	  at	  10%MC,	  we	  found	  that	  methacrylation	  degree	   did	   not	   have	   a	   significant	   effect	   on	   the	   degradation	   of	   our	   sealant.	   	   At	   all	  three	   acrylation	   degrees,	   8%,	   15%,	   20%,	   the	   degradation	   was	   consistent	   in	   both	  volume	  loss	  and	  weight	  loss;	  this	  was	  about	  an	  89%	  loss	  of	  volume	  and	  a	  67%	  loss	  of	  weight	  after	  84	  days,	  Figure	  5a	  i,	  iv-­‐v.	  	  	   Histology	   staining	   was	   performed	   at	   the	   same	   time	   intervals	   to	  determine	  any	  histological	   impact	   from	   introducing	  a	   foreign	  agent	   into	   the	  body.	  Our	  results	  showed	  biocompatibility	  after	  28	  days	  of	   implantation;	   furthermore,	   it	  appeared	  that	  the	  neighboring	  tissue	  formed	  an	  epithelial	   layer	  confluent	  with	  the	  MeTro	  implant.	  The	  H&E	  stain	  revealed	  a	  proper	  cellular	  organization	  of	  the	  tissue	  with	  no	  signs	  of	  inflammation	  or	  necrosis.	  To	  further	  examine	  the	  immune	  response	  of	   the	   tissue	   to	  MeTro,	   an	   immunohistochemistry	   assay	  was	   performed	   targeting	  CD3	  and	  CD68;	  DAPI	  staining	  was	  also	  performed	  to	  show	  the	  presence	  of	  healthy	  
	  29 
cells	   in	   the	   area.	  When	   stained	   for	   CD68,	  monocyte	   specific	   antibody,	  we	   initially	  observed	   monocyte	   infiltration	   after	   three	   days;	   however,	   by	   day	   28	   this	   had	  reduced	  substantially,	  and	  by	  day	  84	  no	  monocytes	  are	  present	  in	  the	  surrounding	  tissue.	   This	   initial	   monocyte	   infiltration	   could	   be	   a	   result	   of	   performing	   the	  experiment	   rather	   than	   a	   side	   effect	   of	   MeTro.	   	   When	   staining	   for	   CD3,	   T-­‐lymphocyte	  specific	  antibody,	  no	  immune	  response	  was	  observed	  in	  any	  of	  the	  time	  frames	  stained.	  The	  absence	  of	  CD3	  in	  the	  surrounding	  tissue	  indicates	  that	  no	  T-­‐cell	  activation	   took	  place	  and	  thus,	   the	  body	  does	  not	  develop	  an	   immune	  response	   to	  our	  sealant.	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Figure	  10:	   Subcutaneous	  Degradation,	  Histology,	  and	   Immunohistochemistry	  of	  MeTro	  after	  
Subcutaneous	   Implantation.	   (a)	  Evaluation	  of	  the	  in	  vivo	  degradation	  of	  MeTro	  hydrogels	  on	  days	  0,	   7,	   28	   and	   84	   of	   implantation.	   (i)	   MeTro	   with	   different	   methacrylation	   degrees	   and	   protein	  concentrations	   were	   subcutaneously	   implanted	   into	   rats.	   Image	   of	   pellet	   from	   subcutaneous	  implantation	  after	  0,	  7,	  28,	  and	  84	  days.	  Graphs	  representing	  the	  degradation	  based	  on	  volume	  loss	  for	   (ii)	   variable	   MeTro	   concentration,	   and	   (iv)	   variable	   methacrylation	   degree.	   Graphs	   depicting	  degradation	   based	   on	  weight	   loss	   of	   pellet	   for	   (iii)	   variable	  MeTro	   concentration,	   and	   (v)	   variable	  methacrylation	  degree.	  (b)	  Histology	  images	  of	  MeTro	  stained	  with	  hematoxylin	  and	  eosin	  after	  (i)	  3	  days,	  (ii)	  28	  days,	  and	  (iii)	  84	  days	  of	  implantation	  in	  subcutaneous	  tissue	  of	  a	  rat	  with	  10%	  MeTro	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concentration	  and	  medium	  methacrylation	  degree.	  (c)	  Immunostaining	  of	  subcutaneously	  implanted	  MeTro	   hydrogels	   showing	   relevant	   macrophage	   detection	   (CD68)	   only	   at	   day	   (i)	   3	   having	  disappeared	  by	  days	  (ii)	  28	  and	  (iii)	  84,	  and	  resulted	  in	  no	  local	  lymphocyte	  infiltration	  (CD3)	  at	  days	  (iv)	  3,	   (v)	  28	  and	  (vi)	  84	   (scale	  bars	  =	  100	  µm).	  Green	  color	   in	   (c)	   represents	   the	  auto-­‐fluorescent	  MeTro,	  red	  color	  the	  immune	  cells,	  and	  blue	  color	  all	  cell	  nuclei	  (DAPI).	  
  
Ex	  Vivo	  Porcine	  Lung	  Model	  
	  Twenty	  successful	  measurements	  were	  performed,	  three	  for	  Evicel,	  Bioglue,	  and	  
the	   Suture	   control,	   six	   measurements	   for	   MeTro	   and	   five	   measurements	   for	   Progel.	  
Each	  measurement	  was	  performed	  on	  a	  single	  lobe	  of	  the	  lung;	  sealants	  were	  randomly	  
assigned	  to	  lobes	  to	  reduce	  variability	  of	  different	  lobes.	  The	  Bioglue	  sealant	  showed	  a	  
significantly	   higher	   burst	   pressure	   than	   all	   of	   the	   other	   sealants:	   Progel	   (P	   ≤	   0.0001),	  
MeTro	   (P	  ≤	  0.001),	  Sutures	   (P	  ≤	  0.0001),	  and	  Evicel	   (P	  ≤	  0.0001).	  The	  MeTro	  did	  show	  
higher	  burst	  pressure	  than	  Progel,	  Evicel	  and	  the	  suture	  control.	  There	  was	  a	  statistically	  
significant	   difference	   in	   means	   of	   MeTro	   compared	   to	   Evicel	   (P≤	   0.001),	   and	   Suture	  
control	   (p	  ≤	  0.05).	  Depending	  on	  the	  sealant,	   the	  minimum	  burst	  pressure	  varied.	  The	  
lowest	  recorded	  burst	  pressure	  was	  for	  Evicel	  at	  10	  cmH2O;	  Progel	  and	  Suture	  Control	  
both	   showed	   a	  minimum	   burst	   pressure	   of	   15	   cmH2O.	  MeTro	   had	   a	  minimum	   of	   22	  
cmH2O	  (burst	  occurred	  during	  increase).	  Bioglue	  did	  not	  achieve	  burst	  up	  to	  50	  cm	  H2O	  
and	  therefore	  does	  not	  have	  a	  minimum	  burst	  pressure.	  	  
There	   are	   several	   different	   types	   of	   bursts	   possible	   from	   the	   sealant	   tissue	  
interaction,	   cohesion	   failure,	   adhesion	   failure,	   and	   tissue	   tearing.	   Cohesion	   failure	   is	  
demonstrated	  by	  a	  rupturing	  of	   the	  sealant	  due	  to	  weak	  mechanical	  properties	  of	   the	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sealant.	  Adhesion	  failure	  occurs	  when	  a	  breach	  in-­‐between	  the	  sealant	  and	  lung	  tissue	  
layer	   allows	   for	   air	   leaks;	   this	   is	   due	   to	   failure	   in	   adherence
 
Figure	  11:	  Ex	  Vivo	  Porcine	  Lung	  Burst	  Pressure.	   	  (i)	  Ex	  Vivo	  burst	  pressure	  setup	  with	  analogue	  volume	  ventilator	  and	  tracheotomy	  tube.	  (ii)	  Fully	  inflated	  pig	  lung.	  (iii)	  Superficial	  wound	  created	  in	  deflated	   lung.	   (iv)	   Wound	   covered	   with	   MeTro	   sealant.	   (v)	   Representative	   graph	   depicting	   the	  incremental	  increase	  in	  pressure	  during	  ventilation.	  	  (vi)	  Average	  burst	  pressures	  for	  MeTro,	  Progel,	  Evicel,	  and	  a	  Suture	  control	  (*p	  <	  0.05,	  **p	  <	  0.01,	  ***p	  <	  0.001,	  ****p	  <	  0.0001).	  	  
 to	  the	  tissue.	  Tissue	  tearing	  is	  observed	  when	  the	  sealant	  itself	  causes	  damage	  to	  the	  tissue;	   this	   is	   commonly	   observed	  when	   the	   sealant	   fails	   to	   expand	  with	   the	   lung	  causing	   the	   tissue	   to	   tear	   (15).	   Depending	   on	   the	   type	   of	   sealant,	   we	   observed	  variable	   bursts.	   Bioglue	   did	   not	   reach	   a	   burst	   pressure	   at	   or	   below	   50	   cm	   H2O	  therefore	  we	  are	  not	  able	  to	  remark	  on	  the	  type	  of	  burst;	  because	  of	  Bioglue’s	  lack	  of	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burst,	   we	   decided	   to	   remove	   the	   data	   from	   Figure	   7.	   Progel	   sealant	   presented	   a	  cohesion	  failure	  four	  out	  of	  the	  six	  times	  the	  experiment	  was	  performed;	  the	  other	  two	  experiments	  resulted	  in	  an	  adhesion	  failure.	  The	  sealant	  had	  an	  average	  burst	  pressure	  of	  25.83	  cmH2O.	  MeTro	  sealant	  resulted	  in	  adhesion	  failure	  six	  out	  of	  the	  seven	  experiments;	  the	  one	  remaining	  experiment	  resulted	  in	  cohesion	  failure.	  This	  sealant	   had	   an	   average	   burst	   pressure	   of	   31.43	   cmH2O.	   Evicel	   sealant	   resulted	   in	  cohesion	   failure	   for	   all	   three	   experiments;	   this	   sealant	   had	   an	   average	   burst	  pressure	   of	   14.3.	   While	   the	   suture	   control	   burst	   type	   cannot	   be	   defined	   by	   the	  parameters	  above,	  it	  had	  an	  average	  burst	  pressure	  of	  18.3	  cmH2O.	  	  
	  
Table	  1:	  Types	  of	  Burst	  Quantified	  using	   the	  Macchiarini	   Scale.	  Data	  for	  Bioglue	  was	  excluded	  because	  it	  did	  not	  exhibit	  a	  burst(14).	  	  	  	  
	  34 
DISCUSSION	  
This	   study	   allowed	   us	   to	   compare	   commercially	   available	   surgical	   sealants	  with	   our	   novel	   sealant	   hydrogel	   MeTro.	   We	   were	   able	   to	   observe	   how	   different	  mechanical	  factors	  such	  as	  elasticity	  and	  adhesiveness	  affect	  the	  burst	  pressure	  in	  ex	  
vivo	   lung	  models.	  The	  similarities	  in	  anatomy	  between	  porcine	  and	  human	  lungs	  is	  well	   established,	   however,	   we	   cannot	   ignore	   the	   differences	   that	   may	   cause	  variation	   in	   the	   data,	   (16).	   Also,	   the	   use	   of	   an	   ex	   vivo	   model	   does	   not	   exactly	  reciprocate	   the	   events	   that	   would	   take	   place	   in	   vivo,	   such	   as	   blood	   flow	   and	   gas	  exchange.	   Further	   testing	   in	   porcine	   in	   vivo	   lung	   models	   will	   be	   necessary	   to	  generate	   more	   relevant	   data.	   Although	   every	   specimen	   was	   similar	   in	   age	   and	  species,	  there	  is	  always	  biological	  variation	  that	  we	  did	  not	  take	  into	  account.	  This	  variation,	  however,	  is	  not	  significant	  because	  practical	  applications	  of	  these	  sealants	  will	  have	  similar	  variation	  based	  on	  patient	  characteristics.	  	  
Our	  study	  exhibited	  much	  variation	  of	  burst	  pressure	  as	  a	  result	  of	  different	  sealant	   properties.	   Bioglue	   was	   the	   only	   sample	   to	   demonstrate	   a	   statistically	  significant	  increase	  in	  burst	  pressure;	  however,	  this	  also	  comes	  with	  its	  limitations	  of	  toxicity	  and	  rigidity.	  It	  was	  very	  clear	  that	  the	  Bioglue	  restricted	  expansion	  of	  the	  lung	  over	  the	  region	  on	  which	  it	  was	  administered;	  also,	  one	  component	  of	  the	  two-­‐part	   sealant	   consists	   of	   glutaraldehyde,	   a	   cytotoxic	   substance.	   MeTro	   sealant	  showed	   the	   highest	   burst	   pressure	   after	   Bioglue;	   also,	  MeTro	   sealant	   showed	   the	  highest	   elastic	   properties	   and	   was	   seen	   expanding	   with	   the	   lung	   tissue	   during	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When	  considering	  the	  use	  of	  surgical	  sealants,	  there	  are	  several	  factors	  that	  need	   to	   be	   considered.	   Sealants	   should	   be	   biocompatible,	   non-­‐toxic,	   and	   easily	  degradable;	   also,	   it	   would	   be	   advantageous	   if	   the	   sealant	   did	   not	   cause	   any	  secondary	  tearing	  in	  the	  tissue,	  as	  this	  would	  defeat	  its	  purpose.	  When	  applying	  the	  sealant,	  one	  should	  consider	  the	  tissue	  it	  will	  be	  adhering	  to	  and	  the	  possible	  forces	  that	  will	  be	  acting	  on	  the	  sealant	  (17).	  	  From	  the	  observations	  made	  in	  our	  study,	  we	  can	  conclude	  that	  MeTro	  sealant	  exhibited	  the	  highest	  combination	  of	  elasticity	  and	  strength.	  




1. Klimczak A, Miroslawska-Kempinska B, Bieganska-Plonka M, Mik M, Dziki A. 
Manual stitching: the past and the present. Polski przeglad chirurgiczny. 2011;83(9):527-
30. doi: 10.2478/v10035-011-0083-8. PubMed PMID: 22166744. 
 
2. Luckachan G, Pillai CKS. Biodegradable Polymers- A Review on Recent Trends 
and Emerging Perspectives2011;- 19(- 3). 
 
3. Duarte AP, Coelho JF, Bordado JC, Cidade MT, Gil MH. Surgical adhesives: 
Systematic review of the main types and development forecast2012;- 37(- 8):- 1050. 
 
4. Annabi N, Tamayol A, Shin SR, Ghaemmaghami AM, Peppas NA, 
Khademhosseini A. Surgical Materials: Current Challenges and Nano-enabled Solutions. 
Nano today. 2014;9(5):574-89. doi: 10.1016/j.nantod.2014.09.006. PubMed PMID: 
25530795; PMCID: 4266934. 
 
5. Ninan L, Stroshine RL, Wilker JJ, Shi R. Adhesive strength and curing rate of 
marine mussel protein extracts on porcine small intestinal submucosa. Acta biomaterialia. 
2007;3(5):687-94. doi: 10.1016/j. Acta biomaterialia.2007.02.004. PubMed PMID: 
17434815; PMCID: 2671012. 
 
6. CoStasis Multi-center Collaborative Writing C. A novel collagen-based 
composite offers effective hemostasis for multiple surgical indications: Results of a 
randomized controlled trial. Surgery. 2001;129(4):445-50. PubMed PMID: 11283536. 
 
7. Chapman WC, Wren SM, Lebovic GS, Malawer M, Sherman R, Block JE. 
Effective management of bleeding during tumor resection with a collagen-based 
hemostatic agent. The American surgeon. 2002;68(9):802-7. PubMed PMID: 12356154. 
 
8. Spotnitz WD, Burks S. Hemostats, sealants, and adhesives: components of the 
surgical toolbox. Transfusion. 2008;48(7):1502-16. doi: 10.1111/j.1537-
2995.2008.01703.x. PubMed PMID: 18422855. 
 
9. Singer AJ, Thode HC, Jr. A review of the literature on octylcyanoacrylate tissue 
adhesive. American journal of surgery. 2004;187(2):238-48. doi: 
10.1016/j.ajsurg.2003.11.017. PubMed PMID: 14769312. 
 
10. Waite JH, Tanzer ML. Polyphenolic Substance of Mytilus edulis: Novel Adhesive 
Containing L-Dopa and Hydroxyproline. Science. 1981;212(4498):1038-40. doi: 
10.1126/Science.212.4498.1038. PubMed PMID: 17779975. 
 
	  38 
11. Wilker JJ. Marine bioinorganic materials: mussels pumping iron. Current opinion 
in chemical biology. 2010;14(2):276-83. doi: 10.1016/j.Comparative Biochemistry and 
Physiology.2009.11.009. PubMed PMID: 20036600. 
 
12. Murphy MP, Aksak B, Sitti M. Gecko-inspired directional and controllable 
adhesion. Small. 2009;5(2):170-5. doi: 10.1002/smll.200801161. PubMed PMID: 
19115348. 
 
13. International A. Standard Test Method for Strength Properties of Tissue 
Adhesives in Lap Shear by Tension Loading. West Conshohocken, PA2010. 
 
14. Macchiarini P, Wain J, Almy S, Dartevelle P. Experimental and clinical 
evaluation of a new synthetic, absorbable sealant to reduce air leaks in thoracic 
operations. The Journal of thoracic and cardiovascular surgery. 1999;117(4):751-8. 
PubMed PMID: 10096971. 
 
15. Pedersen TB, Honge JL, Pilegaard HK, Hasenkam JM. Comparative study of lung 
sealants in a porcine ex vivo model. The Annals of thoracic surgery. 2012;94(1):234-40. 
doi: 10.1016/j.athoracsur.2012.03.050. PubMed PMID: 22560324. 
 
16. Rogers CS, Abraham WM, Brogden KA, Engelhardt JF, Fisher JT, McCray PB, 
Jr., McLennan G, Meyerholz DK, Namati E, Ostedgaard LS, Prather RS, Sabater JR, 
Stoltz DA, Zabner J, Welsh MJ. The porcine lung as a potential model for cystic fibrosis. 
American journal of physiology Lung cellular and molecular physiology. 
2008;295(2):L240-63. doi: 10.1152/ajplung.90203.2008. PubMed PMID: 18487356; 
PMCID: 2519845. 
 
17. Wain JC, Kaiser LR, Johnstone DW, Yang SC, Wright CD, Friedberg JS, Feins 
RH, Heitmiller RF, Mathisen DJ, Selwyn MR. Trial of a novel synthetic sealant in 
preventing air leaks after lung resection. The Annals of thoracic surgery. 












bijand@bu.edu ■ 832-228-3990 
Current Address                                              Permanent Address 
12 Stoneholm Apt 403                                                                                                                             3902 Riley             






Boston University Graduate Medical Sciences; Boston, MA                                                         May 2015 (expected) 
Master of Science in Medical Science GPA 3.82 (pending) 
 
Boston University College of Arts and Science; Boston, MA                                               May 2013  
Bachelor of Arts in Biochemistry and Molecular Biology 
 
MCAT – 33p                                                            September 2012 
 
ACTIVITIES 
• Habitat for Humanity Boston University                                                                                                2012-2013 
o Officer – Treasurer 
• Boston University Global Medical Brigade                                                                                           2011-2012 
o Member  
• Boston University Ski and Snowboard Club                                                                                         2009- 2013 
o Member 




Masters Thesis Candidate Harvard Medical School HST/MIT, Cambridge, MA  
Research Trainee                                                                                                                             May 2014—Present 
• Worked in the lab of Dr. Ali Khademhosseini, primarily focused on tissue engineering and biomaterials. 
• Major contributor to the development of a highly elastic sealant for surgical applications.  
• Designed an experiment to test the biomechanics of a novel stress inducing bioreactor. 
 
Research Mount Sinai School of Medicine, New York, NY  
Research Assistant                                                                                                                     May 2012—mid July 2012 
• Worked with Dr. John Martignetti at Mount Sinai School of Medicine Department of Genetics and Genomic 
Sciences. 
• Assistant to MD PhD post doc, worked on several projects including drug testing on mice for both ovarian 
cancer and obesity. 
• Identified a novel mutation in patient with rare genetic disease, Juvenile Systemic Hyalinosis.  
 
Shadowed OB/GYN Oncology Surgery, New York, NY                                                       May 2012 - mid July 2012 
Shadow 
• Shadowed Dr. Peter Dottino at Mount Sinai School of Medicine 
• I was given the opportunity to scrub-in and observe several hysterectomies and colectomies. 
 
Research Boston University School of Medicine, Boston, MA 
Co-Author- Volunteer                                                                                June 2011- April 2013 
• Worked with Dr. Francis Farraye, Professor of Medicine at BUMC, on the Granuloma Research Project; read 
patients charts, did basic biostatistics, organized the database. 




Shadowed Gastroenterology, Boston, MA 
Shadow                                                                                                                           May 2011- August 2011 
• Shadowed Dr. Francis Farraye, at Boston University School of Medicine. 
• Sat in on scoping procedures: endoscopy, colonoscopy, ileoscopy, etc. 
 
 
Shadowed Orthopedic Surgery, Houston, TX 
Shadow                                                                                             May 2010- August 2010  
• Shadowed Dr. Jonathan Lee, Park Plaza Orthopedic Association; sat in on patient visits for an entire summer. 
• Was taught the basics of orthopedics; learned how to properly read X-Ray imaging. 
 
SKILLS  
• Lab Skills: Standard biochemistry lab techniques, mechanical testing, and basic microfluidic systems. 
 
• Language: Limited conversational and reading skills in Spanish. Advanced conversational skills in Farsi. 
 
INTERESTS 
Science Research: interested in research and advancement of new cancer prevention therapies, infectious diseases, 
tissue engineering, and drug delivery mechanisms.  
Skiing, traveling, and museums.  
